The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

The pharmaceutical company filed its application with the FDA on May 7, and the FDA is expected to finish its approval process by Labor Day weekend.

WASHINGTON, Dec 2 (Reuters) - Britain's initial approval of Pfizer Inc's COVID-19 vaccine should give Americans confidence as the drugmaker next week moves further toward seeking U.S. approval, U.S.

Ten of the twelve former Food and Drug Administration (FDA) commissioners and acting commissioners opposed to the Trump ...

LONDON, Dec 2 (Reuters) - Pfizer (PFE.N), opens new tab is seeking full marketing authorisation from Britain for its COVID-19 vaccine, an executive said on Wednesday as the U.S. drugmaker gears up to ...

The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.